Phytonanomedicine As a Therapeutic Regulator of the Tumor Microenvironment for Inhibiting Cancer Metastasis

Overview

Journal Nanomedicine (Lond)

Specialty Biotechnology

Date 2024 Apr 30

PMID 38686943

Authors

Sonali Sahoo

Sanjeeb Kumar Sahoo

Affiliations

Soon will be listed here.

References

Mohapatra P, Singh P, Sahoo S . Phytonanomedicine: a novel avenue to treat recurrent cancer by targeting cancer stem cells. Drug Discov Today. 2020; 25(8):1307-1321. DOI: 10.1016/j.drudis.2020.06.003. View

Salehi B, Zucca P, Sharifi-Rad M, Pezzani R, Rajabi S, Setzer W . Phytotherapeutics in cancer invasion and metastasis. Phytother Res. 2018; 32(8):1425-1449. DOI: 10.1002/ptr.6087. View

Dhupal M, Chowdhury D . Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use. Int J Nanomedicine. 2020; 15:9125-9157. PMC: 7683832. DOI: 10.2147/IJN.S259628. View

Jain A, Madu C, Lu Y . Phytochemicals in Chemoprevention: A Cost-Effective Complementary Approach. J Cancer. 2021; 12(12):3686-3700. PMC: 8120178. DOI: 10.7150/jca.57776. View

Naeem A, Hu P, Yang M, Zhang J, Liu Y, Zhu W . Natural Products as Anticancer Agents: Current Status and Future Perspectives. Molecules. 2022; 27(23). PMC: 9737905. DOI: 10.3390/molecules27238367. View

Nirmala M, Kizhuveetil U, Johnson A, G B, Nagarajan R, Muthuvijayan V . Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. RSC Adv. 2023; 13(13):8606-8629. PMC: 10013677. DOI: 10.1039/d2ra07863e. View

Kartikasari A, Huertas C, Mitchell A, Plebanski M . Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis. Front Oncol. 2021; 11:692142. PMC: 8294036. DOI: 10.3389/fonc.2021.692142. View

Ko A . Clinical Management: Metastatic Disease. Cancer J. 2017; 23(6):355-361. DOI: 10.1097/PPO.0000000000000294. View

Sa P, Mohapatra P, Swain S, Khuntia A, Sahoo S . Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights. Mol Pharm. 2023; 20(11):5254-5277. DOI: 10.1021/acs.molpharmaceut.3c00286. View

10.

Gerstberger S, Jiang Q, Ganesh K . Metastasis. Cell. 2023; 186(8):1564-1579. PMC: 10511214. DOI: 10.1016/j.cell.2023.03.003. View

11.

Mehan S, Arora N, Bhalla S, Khan A, Rehman M, Alghamdi B . Involvement of Phytochemical-Encapsulated Nanoparticles' Interaction with Cellular Signalling in the Amelioration of Benign and Malignant Brain Tumours. Molecules. 2022; 27(11). PMC: 9182026. DOI: 10.3390/molecules27113561. View

12.

Baranwal J, Barse B, Di Petrillo A, Gatto G, Pilia L, Kumar A . Nanoparticles in Cancer Diagnosis and Treatment. Materials (Basel). 2023; 16(15). PMC: 10420054. DOI: 10.3390/ma16155354. View

13.

Neophytou C, Panagi M, Stylianopoulos T, Papageorgis P . The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities. Cancers (Basel). 2021; 13(9). PMC: 8122975. DOI: 10.3390/cancers13092053. View

14.

Choudhari A, Mandave P, Deshpande M, Ranjekar P, Prakash O . Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. Front Pharmacol. 2020; 10:1614. PMC: 7025531. DOI: 10.3389/fphar.2019.01614. View

15.

Ganesh K, Massague J . Targeting metastatic cancer. Nat Med. 2021; 27(1):34-44. PMC: 7895475. DOI: 10.1038/s41591-020-01195-4. View